ReviewFrontiers in public health2025
Fluorescent labeling of asbestos fiber for enhanced asbestos detection under fluorescence microscopy.
Review in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Automated Fluorescence Microscopy-Based Sensing System for Continuous Detection of Airborne Asbestos Fibers on a PMSensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The application of fluorescence microscopy (FM) for detecting micro- and nano-scale inorganic materials has historically been limited by the lack of specific fluorescent probes. However, recent research has demonstrated that asbestos-binding proteins can act as effective fluorescent probes, significantly enhancing the sensitivity and selectivity of FM for asbestos fiber detection. This advancement enables the identification of nano-scale fibers at lower magnifications, reducing the labor costs associated with asbestos contamination detection. Based on these advantages, two FM-based methods have been developed: (i) phase-contrast microscopy (PCM)-FM, a differential counting approach fully compatible with PCM-based epidemiological data, and (ii) portable FM, which shows strong potential for rapid on-site asbestos screening. Additionally, FM may enable multicolor labeling and live-cell fluorescent imaging of asbestos, opening new avenues for asbestos research. Despite these advancements, several challenges remain. Fluorescent probes alone cannot definitively identify asbestos, and issues such as cross-reactivity need to be addressed. This review highlights future perspectives and challenges for advancing FM methods in asbestos detection and research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.